BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32678339)

  • 1. Gene selection for the Australian Reproductive Genetic Carrier Screening Project ("Mackenzie's Mission").
    Kirk EP; Ong R; Boggs K; Hardy T; Righetti S; Kamien B; Roscioli T; Amor DJ; Bakshi M; Chung CWT; Colley A; Jamieson RV; Liebelt J; Ma A; Pachter N; Rajagopalan S; Ravine A; Wilson M; Caruana J; Casella R; Davis M; Edwards S; Archibald A; McGaughran J; Newson AJ; Laing NG; Delatycki MB
    Eur J Hum Genet; 2021 Jan; 29(1):79-87. PubMed ID: 32678339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation.
    Archibald AD; McClaren BJ; Caruana J; Tutty E; King EA; Halliday JL; Best S; Kanga-Parabia A; Bennetts BH; Cliffe CC; Madelli EO; Ho G; Liebelt J; Long JC; Braithwaite J; Kennedy J; Massie J; Emery JD; McGaughran J; Marum JE; Boggs K; Barlow-Stewart K; Burnett L; Dive L; Freeman L; Davis MR; Downes MJ; Wallis M; Ferrie MM; Pachter N; Scuffham PA; Casella R; Allcock RJN; Ong R; Edwards S; Righetti S; Lunke S; Lewis S; Walker SP; Boughtwood TF; Hardy T; Newson AJ; Kirk EP; Laing NG; Delatycki MB; The Mackenzie's Mission Study Team
    J Pers Med; 2022 Oct; 12(11):. PubMed ID: 36579509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners.
    Delatycki MB; Laing NG; Moore SJ; Emery J; Archibald AD; Massie J; Kirk EP
    Aust J Gen Pract; 2019 Mar; 48(3):106-110. PubMed ID: 31256466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and use of the Australian reproductive genetic carrier screening decision aid.
    King E; Halliday J; Archibald AD; Delatycki M; Barlow-Stewart K; Newson AJ; McClaren BJ
    Eur J Hum Genet; 2022 Feb; 30(2):194-202. PubMed ID: 34725472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
    Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User Acceptability of Whole Exome Reproductive Carrier Testing for Consanguineous Couples in Australia.
    Josephi-Taylor S; Barlow-Stewart K; Selvanathan A; Roscioli T; Bittles A; Meiser B; Worgan L; Rajagopalan S; Colley A; Kirk EP
    J Genet Couns; 2019 Apr; 28(2):240-250. PubMed ID: 30964588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views of reproductive genetic carrier screening participants regarding screening for genes associated with non-syndromic hearing loss.
    Freeman L; Delatycki MB; Leach Scully J; Kirk EP
    Prenat Diagn; 2022 Dec; 42(13):1658-1666. PubMed ID: 36289583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.
    Van Steijvoort E; Chokoshvili D; W Cannon J; Peeters H; Peeraer K; Matthijs G; Borry P
    Hum Reprod Update; 2020 Apr; 26(3):335-355. PubMed ID: 32099997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology.
    Xi Y; Chen G; Lei C; Wu J; Zhang S; Xiao M; Zhang W; Zhang Y; Sun X
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1340. PubMed ID: 32573981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which types of conditions should be included in reproductive genetic carrier screening? Views of parents of children with a genetic condition.
    Thomas LA; Lewis S; Massie J; Kirk EP; Archibald AD; Barlow-Stewart K; Boardman FK; Halliday J; McClaren B; Delatycki MB
    Eur J Med Genet; 2020 Dec; 63(12):104075. PubMed ID: 33007447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and classification of severity for 176 genes on an expanded carrier screening panel.
    Arjunan A; Bellerose H; Torres R; Ben-Shachar R; Hoffman JD; Angle B; Slotnick RN; Simpson BN; Lewis AM; Magoulas PL; Bontempo K; Schulze J; Tarpinian J; Bucher JA; Dineen R; Goetsch A; Lazarin GA; Johansen Taber K
    Prenat Diagn; 2020 Sep; 40(10):1246-1257. PubMed ID: 32474937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The more you do it, the easier it gets: using behaviour change theory to support health care professionals offering reproductive genetic carrier screening.
    Best S; Long JC; Fehlberg Z; Theodorou T; Hatem S; Archibald A; Braithwaite J
    Eur J Hum Genet; 2023 Apr; 31(4):430-444. PubMed ID: 36424524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons affecting the uptake of reproductive genetic carrier screening among nonpregnant reproductive-aged women in Flanders (Belgium).
    Van Steijvoort E; Demuynck R; Peeters H; Vandecruys H; Verguts J; Peeraer K; Matthijs G; Borry P
    J Genet Couns; 2022 Oct; 31(5):1043-1053. PubMed ID: 35385167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counseling for personal health implications identified during reproductive genetic carrier screening.
    Gbur S; Mauney L; Gray KJ; Wilkins-Haug L; Guseh S
    Prenat Diagn; 2021 Oct; 41(11):1460-1466. PubMed ID: 34426984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical considerations in gene selection for reproductive carrier screening.
    Dive L; Archibald AD; Newson AJ
    Hum Genet; 2022 May; 141(5):1003-1012. PubMed ID: 34426854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded carrier screening: A current perspective.
    Mastantuoni E; Saccone G; Al-Kouatly HB; Paternoster M; D'Alessandro P; Arduino B; Carbone L; Esposito G; Raffone A; De Vivo V; Maruotti GM; Berghella V; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():41-54. PubMed ID: 30240948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.
    Beard CA; Amor DJ; Di Pietro L; Archibald AD
    Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines.
    Johansen Taber K; Lim-Harashima J; Naemi H; Goldberg J
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1024. PubMed ID: 31694075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaling-up and future sustainability of a national reproductive genetic carrier screening program.
    Fehlberg Z; Best S; Long JC; Theodorou T; Pope C; Hibbert P; Williams S; Freeman L; Righetti S; Archibald AD; Braithwaite J
    NPJ Genom Med; 2023 Jul; 8(1):18. PubMed ID: 37524740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.